DAX19.060 -0,7%ESt504.751 -0,8%MSCIW3.730 +0,2%Dow43.248 -0,3%Nas18.883 +0,5%Bitcoin87.434 +2,3%Euro1,0586 -0,1%Öl73,22 +0,1%Gold2.633 +0,8%
Beliebte Suche
DAX 40 Ölpreis Euro - Dollar Bitcoin - Euro Goldpreis
Meistgesucht
NVIDIA 918422 Tesla A1CX3T Rheinmetall 703000 Super Micro Computer A40MRM Bayer BAY001 Palantir A2QA4J MicroStrategy 722713 EVOTEC 566480 Siemens Energy ENER6Y thyssenkrupp 750000 Amazon 906866 Volkswagen (VW) vz. 766403 Mercedes-Benz Group (ex Daimler) 710000 Coinbase A2QP7J RENK RENK73
Alle Aktien für 0 Euro (zzgl. Spreads) handeln mit finanzen.net zero. Hier informieren
Heute im Fokus
DAX beendet Handel knapp über 19.000 Punkten -- thyssenkrupp meldet erneut Milliardenverlust -- Rivian-CFO will sich von Millionen Rivian-Aktien trennen -- Super Micro, Xpeng im Fokus
Top News
Gewinne in New York: NASDAQ 100 notiert im Plus Gewinne in New York: NASDAQ 100 notiert im Plus
S&P 500-Handel aktuell: S&P 500 präsentiert sich am Mittag fester S&P 500-Handel aktuell: S&P 500 präsentiert sich am Mittag fester
Suche...
Login
ODER

Neu auf finanzen.net?

Kostenfrei registrieren und Vorteile nutzen

Übersicht Wertpapierdepots Musterdepots Watchlists Meine News Newsletter Forum Trading Desk Apps Social Media Podcasts
Profil

BioNTech (ADRs) Aktie

NeuKaufenVerkaufen
Aktien-Sparplan anlegen
99,75 EUR +4,75 EUR +5,00 %
FSE
Aktien, ETFs, Sparpläne & Kryptos zu Top-Konditionen beim Testsieger von finanztip.de handeln!
JETZT LOSLEGEN
Du hast schon ein ZERO-Konto? Direkt handeln bei ZERO!Bei einem anderen Broker handelnSmartphone

Marktkap.22,58 Mrd. EUR

KGV25,25Div. Rendite0,00%

WKNA2PSR2

ISINUS09075V1026

SymbolBNTX

BioNTech (ADRs) Aktien News

DatumMeistgelesen
PR NewswireSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of BioNTech SE - BNTX
RSS6-K: Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
GlobeNewswireBioNTech Presents Positive Phase 1/2 Data Update for CAR-T Cell Therapy Candidate BNT211 in Advanced Solid Tumors at ESMO Congress 2023
GlobeNewswireBioNTech to Report Third Quarter Financial Results and Corporate Update on November 6, 2023, And to Host Innovation Series Day on November 7, 2023
GlobeNewswireBioNTech Expands Late-Stage Clinical Oncology Portfolio with Initiation of further Phase 2 Trial with mRNA-based Individualized Neoantigen Specific Immunotherapy in New Cancer Indication
PR NewswireSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of BioNTech SE - BNTX
RSS6-K: Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
GlobeNewswireBioNTech to Present Multiple Program Updates Across Modalities at ESMO Congress 2023
GlobeNewswireUpdate Regarding Pfizer’s Statement on COMIRNATY-Related Write-Offs
RSS144/A: Amendment to a previously filed 144
RSS144: Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing
PR NewswirePfizer and BioNTech Receive Health Canada Authorization for XBB.1.5-Adapted Monovalent COVID-19 Vaccine
PR NewswirePfizer and BioNTech Receive Health Canada Authorization for XBB.1.5-Adapted Monovalent COVID-19 Vaccine
GlobeNewswireBioNTech and CEPI Announce Partnership to Advance mRNA Mpox Vaccine Development and Support CEPI’s 100 Days Mission
RSS6-K: Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
GlobeNewswirePfizer and BioNTech Receive Positive CHMP Opinion for Omicron XBB.1.5-adapted COVID-19 Vaccine in the European Union
RSS144/A: Amendment to a previously filed 144
RSS6-K: Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
GlobeNewswireBioNTech Expands Management Board by Appointing James Ryan as Chief Legal Officer
RSS6-K: Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
GlobeNewswireBioNTech Announces Second Quarter 2023 Financial Results and Corporate Update
GlobeNewswireBioNTech Completes Acquisition of InstaDeep
GlobeNewswireBioNTech to Report Second Quarter 2023 Financial Results and Operational Update on August 7, 2023
RSS6-K: Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
GlobeNewswireBioNTech and OncoC4 Initiate Pivotal Phase 3 Trial of BNT316/ONC-392 Program in Metastatic NSCLC
RSS144: Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing
GlobeNewswireBioNTech and OncoC4 Present Positive Phase 1/2 Data for Antibody Candidate BNT316/ONC-392 in Hard-to-Treat NSCLC at ASCO
RSS6-K: Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
GlobeNewswireBioNTech Announces First Quarter 2023 Financial Results and Corporate Update
GlobeNewswireBioNTech to Report First Quarter 2023 Financial Results and Operational Update on May 8, 2023
RSS6-K: Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
RSS6-K: Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
GlobeNewswireBioNTech and DualityBio Form Global Strategic Partnership to Accelerate Development of Differentiated Antibody-Drug Conjugate Therapeutics for Solid Tumors
GlobeNewswireBioNTech Announces New ADS Repurchase Program
RSS20-F: Registration of securities of foreign private issuers pursuant to section 12(b) or (g)
RSS6-K: Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
GlobeNewswireBioNTech Announces Fourth Quarter and Full Year 2022 Financial Results and Corporate Update
GlobeNewswireBioNTech and OncoC4 Announce Strategic Collaboration to Co-Develop and Commercialize Novel Checkpoint Antibody in Multiple Solid Tumor Indications
RSS6-K: Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
GlobeNewswireBioNTech to Report Full Year and Fourth Quarter 2022 Financial Results and Operational Update on March 27, 2023

BioNTech (ADRs) News

BioNTech (ADRs) News: auf dieser Seite finden Sie alle BioNTech (ADRs) News und Nachrichten zur BioNTech (ADRs) Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch BioNTech (ADRs) News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um BioNTech (ADRs) News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.